Search

Karen C. Carlson

Examiner (ID: 1828, Phone: (571)272-0946 , Office: P/1656 )

Most Active Art Unit
1656
Art Unit(s)
1653, 1652, 1635, 1642, 1801, 1611, 1812, 1814, 1656, 1651
Total Applications
2193
Issued Applications
1462
Pending Applications
175
Abandoned Applications
558

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17822705 [patent_doc_number] => 11427643 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-30 [patent_title] => Targeted protein degradation [patent_app_type] => utility [patent_app_number] => 16/879896 [patent_app_country] => US [patent_app_date] => 2020-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16959 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16879896 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/879896
Targeted protein degradation May 20, 2020 Issued
Array ( [id] => 18412114 [patent_doc_number] => 11666641 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-06-06 [patent_title] => CRISPR nuclease [patent_app_type] => utility [patent_app_number] => 17/594761 [patent_app_country] => US [patent_app_date] => 2020-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 23807 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594761 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/594761
CRISPR nuclease Apr 29, 2020 Issued
Array ( [id] => 17207751 [patent_doc_number] => 11168110 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-09 [patent_title] => Method for separation of monomeric polypeptides from aggregated polypeptides [patent_app_type] => utility [patent_app_number] => 16/851458 [patent_app_country] => US [patent_app_date] => 2020-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10988 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16851458 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/851458
Method for separation of monomeric polypeptides from aggregated polypeptides Apr 16, 2020 Issued
Array ( [id] => 17845118 [patent_doc_number] => 11434474 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-06 [patent_title] => Modulation of lipid metabolism for protein production [patent_app_type] => utility [patent_app_number] => 16/818162 [patent_app_country] => US [patent_app_date] => 2020-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 32 [patent_no_of_words] => 28719 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16818162 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/818162
Modulation of lipid metabolism for protein production Mar 12, 2020 Issued
Array ( [id] => 17968259 [patent_doc_number] => 11485773 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-11-01 [patent_title] => Protease inhibitor:protease sensitive expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria [patent_app_type] => utility [patent_app_number] => 16/818631 [patent_app_country] => US [patent_app_date] => 2020-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 30 [patent_no_of_words] => 11950 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16818631 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/818631
Protease inhibitor:protease sensitive expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria Mar 12, 2020 Issued
Array ( [id] => 17742831 [patent_doc_number] => 11390888 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-19 [patent_title] => Methods for genomic integration [patent_app_type] => utility [patent_app_number] => 16/816172 [patent_app_country] => US [patent_app_date] => 2020-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 36 [patent_no_of_words] => 38850 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16816172 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/816172
Methods for genomic integration Mar 10, 2020 Issued
Array ( [id] => 16204892 [patent_doc_number] => 20200237882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-30 [patent_title] => Compositions and Methods for Treating Pathological Calcification and Ossification [patent_app_type] => utility [patent_app_number] => 16/813315 [patent_app_country] => US [patent_app_date] => 2020-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25825 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16813315 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/813315
Compositions and methods for treating pathological calcification and ossification Mar 8, 2020 Issued
Array ( [id] => 16500064 [patent_doc_number] => 10865441 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-15 [patent_title] => Mutant Taq polymerase for faster amplification [patent_app_type] => utility [patent_app_number] => 16/813425 [patent_app_country] => US [patent_app_date] => 2020-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8964 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 214 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16813425 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/813425
Mutant Taq polymerase for faster amplification Mar 8, 2020 Issued
Array ( [id] => 16343967 [patent_doc_number] => 20200308617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-01 [patent_title] => METHODS FOR IMPROVED PRODUCTION OF REBAUDIOSIDE D AND REBAUDIOSIDE M [patent_app_type] => utility [patent_app_number] => 16/799541 [patent_app_country] => US [patent_app_date] => 2020-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34017 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16799541 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/799541
Methods for improved production of Rebaudioside D and Rebaudioside M Feb 23, 2020 Issued
Array ( [id] => 16009381 [patent_doc_number] => 20200179533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-11 [patent_title] => THYMIDINE KINASE GENE [patent_app_type] => utility [patent_app_number] => 16/798198 [patent_app_country] => US [patent_app_date] => 2020-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38470 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -63 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16798198 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/798198
Thymidine kinase gene Feb 20, 2020 Issued
Array ( [id] => 17133150 [patent_doc_number] => 11134681 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-10-05 [patent_title] => Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing [patent_app_type] => utility [patent_app_number] => 16/785870 [patent_app_country] => US [patent_app_date] => 2020-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19107 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16785870 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/785870
Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing Feb 9, 2020 Issued
Array ( [id] => 16238577 [patent_doc_number] => 20200255811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-13 [patent_title] => PHOSPHOTRIESTERASE ENZYME TETHERED MONOMER [patent_app_type] => utility [patent_app_number] => 16/783841 [patent_app_country] => US [patent_app_date] => 2020-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10027 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16783841 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/783841
PHOSPHOTRIESTERASE ENZYME TETHERED MONOMER Feb 5, 2020 Abandoned
Array ( [id] => 16525538 [patent_doc_number] => 20200399618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-24 [patent_title] => Compositions and Methods for Pesticide Degradation [patent_app_type] => utility [patent_app_number] => 16/778653 [patent_app_country] => US [patent_app_date] => 2020-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6523 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16778653 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/778653
Compositions and Methods for Pesticide Degradation Jan 30, 2020 Abandoned
Array ( [id] => 15931765 [patent_doc_number] => 20200157516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-21 [patent_title] => PEPTIDE-MEDIATED DELIVERY OF RNA-GUIDED ENDONUCLEASE INTO CELLS [patent_app_type] => utility [patent_app_number] => 16/752887 [patent_app_country] => US [patent_app_date] => 2020-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43640 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16752887 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/752887
PEPTIDE-MEDIATED DELIVERY OF RNA-GUIDED ENDONUCLEASE INTO CELLS Jan 26, 2020 Abandoned
Array ( [id] => 17664156 [patent_doc_number] => 11357832 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-14 [patent_title] => Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of iduronate-2-sulfatase [patent_app_type] => utility [patent_app_number] => 16/744140 [patent_app_country] => US [patent_app_date] => 2020-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 27696 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16744140 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/744140
Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of iduronate-2-sulfatase Jan 14, 2020 Issued
Array ( [id] => 17088626 [patent_doc_number] => 11116796 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-09-14 [patent_title] => Nanoparticle formulations [patent_app_type] => utility [patent_app_number] => 16/742082 [patent_app_country] => US [patent_app_date] => 2020-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 32 [patent_no_of_words] => 21044 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 299 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16742082 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/742082
Nanoparticle formulations Jan 13, 2020 Issued
Array ( [id] => 15899011 [patent_doc_number] => 20200149024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-14 [patent_title] => Engineered CRISPR-Cas9 Nucleases [patent_app_type] => utility [patent_app_number] => 16/734935 [patent_app_country] => US [patent_app_date] => 2020-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20338 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -41 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16734935 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/734935
Engineered CRISPR-Cas9 nucleases Jan 5, 2020 Issued
Array ( [id] => 15769435 [patent_doc_number] => 20200115735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-16 [patent_title] => NOVEL LUCIFERASE SEQUENCES UTILIZING INFRARED-EMITTING SUBSTRATES TO PRODUCE ENHANCED LUMINESCENCE [patent_app_type] => utility [patent_app_number] => 16/725586 [patent_app_country] => US [patent_app_date] => 2019-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27864 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16725586 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/725586
Luciferase sequences utilizing infrared-emitting substrates to produce enhanced luminescence Dec 22, 2019 Issued
Array ( [id] => 16175546 [patent_doc_number] => 20200222514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-16 [patent_title] => CARBAPENEMASES FOR USE WITH ANTIBIOTICS FOR THE PROTECTION OF THE INTESTINAL MICROBIOME [patent_app_type] => utility [patent_app_number] => 16/720999 [patent_app_country] => US [patent_app_date] => 2019-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46599 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16720999 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/720999
Carbapenemases for use with antibiotics for the protection of the intestinal microbiome Dec 18, 2019 Issued
Array ( [id] => 17029576 [patent_doc_number] => 11091380 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-17 [patent_title] => Composition and methods of use [patent_app_type] => utility [patent_app_number] => 16/707367 [patent_app_country] => US [patent_app_date] => 2019-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 12 [patent_no_of_words] => 14083 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16707367 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/707367
Composition and methods of use Dec 8, 2019 Issued
Menu